David Toung
Stock Analyst at Argus Research
(2.15)
# 3,434
Out of 4,953 analysts
125
Total ratings
71.43%
Success rate
1.21%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Reiterates: Hold | $282 | $288.25 | -2.17% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $312.00 | - | 4 | Jul 21, 2025 | |
| GFS GlobalFoundries | Initiates: Buy | $52 | $33.22 | +56.53% | 1 | Jul 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $498.29 | -5.68% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $304.24 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $14.69 | - | 2 | Mar 31, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $206.19 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $149.02 | -16.12% | 9 | Sep 11, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $158.48 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $295.55 | +15.04% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $676.91 | -1.02% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $104.31 | +43.80% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $703.21 | +19.45% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $67.82 | +40.08% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $73.97 | +48.71% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $275.77 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.32 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $389.94 | -20.50% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $402.69 | -23.02% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $479.20 | -33.22% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $131.25 | +2.86% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $117.98 | -36.43% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $48.34 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $84.93 | +29.52% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $89.90 | +83.54% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.34 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $54.87 | +123.25% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $79.54 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $124.95 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $177.80 | -12.82% | 4 | Mar 27, 2020 |
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $288.25
Upside: -2.17%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $312.00
Upside: -
GlobalFoundries
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $33.22
Upside: +56.53%
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $498.29
Upside: -5.68%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $304.24
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $14.69
Upside: -
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $206.19
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $149.02
Upside: -16.12%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $158.48
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $295.55
Upside: +15.04%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $676.91
Upside: -1.02%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $104.31
Upside: +43.80%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $703.21
Upside: +19.45%
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $67.82
Upside: +40.08%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $73.97
Upside: +48.71%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $275.77
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $25.32
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $389.94
Upside: -20.50%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $402.69
Upside: -23.02%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $479.20
Upside: -33.22%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $131.25
Upside: +2.86%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $117.98
Upside: -36.43%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $48.34
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $84.93
Upside: +29.52%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $89.90
Upside: +83.54%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.34
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $54.87
Upside: +123.25%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $79.54
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $124.95
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $177.80
Upside: -12.82%